Treating infectious diseases by targeting the human glycome
Treating infectious diseases by targeting the human glycome
Pneumagen is developing a glycan targeted intranasally delivered therapy for the pan-viral, universal treatment of infectious diseases of the respiratory tract
Latest news
08 Mar, 2021
Pneumagen Announces Neumifil™ is Efficacious In an Established Model of COVID-19 Infection